Comparative proteomic analysis implicates COMMD proteins as epstein-barr virus targets in the BL41 Burkitt's lymphoma cell line

Journal of Proteome Research

Volumn 10, Issue 7, 2011, Pages 2959-2968

  Gkiafi, Zacharati ^a   Panayotou, George ^a  

^a BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; COPPER METABOLISM MURR1 1 PROTEIN; COPPER METABOLISM MURR1 10 PROTEIN; COPPER METABOLISM MURR1 2 PROTEIN; COPPER METABOLISM MURR1 3 PROTEIN; COPPER METABOLISM MURR1 4 PROTEIN; COPPER METABOLISM MURR1 5 PROTEIN; COPPER METABOLISM MURR1 6 PROTEIN; COPPER METABOLISM MURR1 7 PROTEIN; COPPER METABOLISM MURR1 8 PROTEIN; COPPER METABOLISM MURR1 9 PROTEIN; COPPER METABOLISM MURR1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPHOMA CELL; LYMPHOMA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; VIRUS CELL INTERACTION; WESTERN BLOTTING;

B-LYMPHOCYTES; BLOTTING, WESTERN; BURKITT LYMPHOMA; CARRIER PROTEINS; CELL TRANSFORMATION, VIRAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; NF-KAPPA B; PROTEIN ISOFORMS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TANDEM MASS SPECTROMETRY; TUMOR CELLS, CULTURED;

HUMAN HERPESVIRUS 4;

EID: 79959997980     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100793m     Document Type: Article

References (63)

1. Thorley-Lawson, D. A.; Allday, M. J. The curious case of the tumour virus: 50 years of Burkitt's lymphoma Nat. Rev. Microbiol. 2008, 6 (12) 913-24
2. Young, L. S.; Dawson, C. W.; Eliopoulos, A. G. The expression and function of Epstein-Barr virus encoded latent genes Mol. Pathol. 2000, 53 (5) 238-47
3. Thorley-Lawson, D. A. EBV the prototypical human tumor virus - just how bad is it? J. Allergy Clin. Immunol. 2005, 116 (2) 251-61; quiz 262 (Pubitemid 41096526)
4. Mosialos, G.; Birkenbach, M.; Yalamanchili, R.; VanArsdale, T.; Ware, C.; Kieff, E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family Cell 1995, 80 (3) 389-99
5. Eliopoulos, A. G.; Caamano, J. H.; Flavell, J.; Reynolds, G. M.; Murray, P. G.; Poyet, J. L.; Young, L. S. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway Oncogene 2003, 22 (48) 7557-69 (Pubitemid 37464088)
6. Kaye, K. M.; Izumi, K. M.; Kieff, E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation Proc. Natl. Acad. Sci. U.S.A. 1993, 90 (19) 9150-4 (Pubitemid 23306469)
7. Kilger, E.; Kieser, A.; Baumann, M.; Hammerschmidt, W. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor EMBO J. 1998, 17 (6) 1700-9 (Pubitemid 28119123)
8. Soni, V.; Cahir-McFarland, E.; Kieff, E. LMP1 TRAFficking activates growth and survival pathways Adv. Exp. Med. Biol. 2007, 597, 173-87
9. Rowe, M.; Rooney, C. M.; Edwards, C. F.; Lenoir, G. M.; Rickinson, A. B. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma Int. J. Cancer 1986, 37 (3) 367-73 (Pubitemid 16160766)
10. Calender, A.; Billaud, M.; Aubry, J. P.; Banchereau, J.; Vuillaume, M.; Lenoir, G. M. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells Proc. Natl. Acad. Sci. U.S.A. 1987, 84 (22) 8060-4 (Pubitemid 18094057)
11. Cahir-McFarland, E. D.; Carter, K.; Rosenwald, A.; Giltnane, J. M.; Henrickson, S. E.; Staudt, L. M.; Kieff, E. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells J. Virol. 2004, 78 (8) 4108-19 (Pubitemid 38437217)
12. Cohen, J. H.; Fischer, E.; Kazatchkine, M. D.; Lenoir, G. M.; Lefevre-Delvincourt, C.; Revillard, J. P. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines Scand. J. Immunol. 1987, 25 (6) 587-98
13. Carter, K. L.; Cahir-McFarland, E.; Kieff, E. Epstein-barr virus-induced changes in B-lymphocyte gene expression J. Virol. 2002, 76 (20) 10427-36
14. Longnecker, R. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence? Adv. Cancer Res. 2000, 79, 175-200
15. Toda, T.; Sugimoto, M.; Omori, A.; Matsuzaki, T.; Furuichi, Y.; Kimura, N. Proteomic analysis of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines before and after immortalization Electrophoresis 2000, 21 (9) 1814-22 (Pubitemid 30394873)
16. Brennan, P.; Angharad, M. S.; Mathew, C.; Saman, H.; Catrin, M. J.; Peter, G.; Christopher, F.; Christopher, P.; Ian, A. B. Quantitative nuclear proteomics reveals new phenotypes altered in lymphoblastoid cells Proteomics: Clin. Appl. 2009, 3 (3) 359-69
17. Srivastava, S.; Verma, M.; Gopal-Srivastava, R. Proteomic maps of the cancer-associated infectious agents J. Proteome Res. 2005, 4 (4) 1171-1180 (Pubitemid 41208675)
18. Baran-Marszak, F.; Fagard, R.; Girard, B.; Camilleri-Broet, S.; Zeng, F.; Lenoir, G. M.; Raphael, M.; Feuillard, J. Gene array identification of Epstein-Barr virus-regulated cellular genes in EBV-converted Burkitt lymphoma cell lines Lab Invest. 2002, 82 (11) 1463-79 (Pubitemid 35332906)
19. Baik, S. Y.; Yun, H. S.; Lee, H. J.; Lee, M. H.; Jung, S. E.; Kim, J. W.; Jeon, J. P.; Shin, Y. K.; Rhee, H. S.; Kimm, K. C.; Han, B. G. Identification of stathmin 1 expression induced by Epstein-Barr virus in human B lymphocytes Cell Prolif. 2007, 40 (2) 268-81 (Pubitemid 46398818)
20. Craig, F. E.; Johnson, L. R.; Harvey, S. A.; Nalesnik, M. A.; Luo, J. H.; Bhattacharya, S. D.; Swerdlow, S. H. Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders Diagn. Mol. Pathol. 2007, 16 (3) 158-68 (Pubitemid 47329876)
21. Faumont, N.; Durand-Panteix, S.; Schlee, M.; Gromminger, S.; Schuhmacher, M.; Holzel, M.; Laux, G.; Mailhammer, R.; Rosenwald, A.; Staudt, L. M.; Bornkamm, G. W.; Feuillard, J. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells J. Virol. 2009, 83 (10) 5014-27
22. Yan, G.; Li, L.; Tao, Y.; Liu, S.; Liu, Y.; Luo, W.; Wu, Y.; Tang, M.; Dong, Z.; Cao, Y. Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology Proteomics 2006, 6 (6) 1810-21
23. Frasca, D.; Riley, R. L.; Blomberg, B. B. Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF Exp. Gerontol. 2007, 42 (3) 192-203 (Pubitemid 46109561)
24. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels Anal. Chem. 1996, 68 (5) 850-8
25. Rosenfeld, J.; Capdevielle, J.; Guillemot, J. C.; Ferrara, P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis Anal. Biochem. 1992, 203 (1) 173-9
26. Laird, P. W.; Zijderveld, A.; Linders, K.; Rudnicki, M. A.; Jaenisch, R.; Berns, A. Simplified mammalian DNA isolation procedure Nucleic Acids Res. 1991, 19 (15) 4293
27. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res. 2001, 29 (9) e45
28. Ramakers, C.; Ruijter, J. M.; Deprez, R. H.; Moorman, A. F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data Neurosci. Lett. 2003, 339 (1) 62-6 (Pubitemid 36263221)
29. Silins, S. L.; Sculley, T. B. Modulation of vimentin, the CD40 activation antigen and Burkitt's lymphoma antigen (CD77) by the Epstein-Barr virus nuclear antigen EBNA-4 Virology 1994, 202 (1) 16-24
30. Petrak, J.; Ivanek, R.; Toman, O.; Cmejla, R.; Cmejlova, J.; Vyoral, D.; Zivny, J.; Vulpe, C. D. Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins Proteomics 2008, 8 (9) 1744-9 (Pubitemid 351678270)
31. Wang, P.; Bouwman, F. G.; Mariman, E. C. Generally detected proteins in comparative proteomics - a matter of cellular stress response? Proteomics 2009, 9 (11) 2955-66
32. Barel, M.; Balbo, M.; Gauffre, A.; Frade, R. Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoprotein Mol. Immunol. 1995, 32 (6) 389-97
33. Birkenbach, M.; Josefsen, K.; Yalamanchili, R.; Lenoir, G.; Kieff, E. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors J. Virol. 1993, 67 (4) 2209-20 (Pubitemid 23088397)
34. Blum, K. A.; Lozanski, G.; Byrd, J. C. Adult Burkitt leukemia and lymphoma Blood 2004, 104 (10) 3009-20 (Pubitemid 39507113)
35. Lee, S. H.; Vidal, S. M. Functional diversity of Mx proteins: variations on a theme of host resistance to infection Genome Res. 2002, 12 (4) 527-30 (Pubitemid 34308632)
36. Classen, C. F.; Bird, P. I.; Debatin, K. M. Modulation of the granzyme B inhibitor proteinase inhibitor 9 (PI-9) by activation of lymphocytes and monocytes in vitro and by Epstein-Barr virus and bacterial infection Clin. Exp. Immunol. 2006, 143 (3) 534-42
37. Ovaa, H.; Kessler, B. M.; Rolen, U.; Galardy, P. J.; Ploegh, H. L.; Masucci, M. G. Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (8) 2253-8 (Pubitemid 38269298)
38. Ai, M. D.; Li, L. L.; Zhao, X. R.; Wu, Y.; Gong, J. P.; Cao, Y. Regulation of survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines Cell Res. 2005, 15 (10) 777-84 (Pubitemid 41653915)
39. Newkirk, M. M.; Tsoukas, C. Effect of ultraviolet irradiation on selected host cell proteins including Ro/SS-A and Epstein-Barr virus in cultured lymphoblastoid cell lines J. Autoimmun. 1992, 5 (4) 511-25
40. Lin, X.; Liu, S.; Luo, X.; Ma, X.; Guo, L.; Li, L.; Li, Z.; Tao, Y.; Cao, Y. EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells Int. J. Cancer 2009, 124 (5) 1020-7
41. Toda, T.; Sugimoto, M. Proteome analysis of Epstein-Barr virus-transformed B-lymphoblasts and the proteome database J. Chromatogr., B 2003, 787 (1) 197-206 (Pubitemid 36351274)
42. Forsman, A.; Ruetschi, U.; Ekholm, J.; Rymo, L. Identification of intracellular proteins associated with the EBV-encoded nuclear antigen 5 using an efficient TAP procedure and FT-ICR mass spectrometry J. Proteome Res. 2008, 7 (6) 2309-19
43. Salama, I.; Malone, P. S.; Mihaimeed, F.; Jones, J. L. A review of the S100 proteins in cancer Eur. J. Surg. Oncol. 2008, 34 (4) 357-64 (Pubitemid 351381290)
44. Bukrinsky, M. How to engage Cofilin Retrovirology 2008, 5, 85
45. Arlt, A.; Bauer, I.; Schafmayer, C.; Tepel, J.; Muerkoster, S. S.; Brosch, M.; Roder, C.; Kalthoff, H.; Hampe, J.; Moyer, M. P.; Folsch, U. R.; Schafer, H. Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2) Oncogene 2009, 28 (45) 3983-96
46. Nagata, K.; Asano, T.; Nozawa, Y.; Inagaki, M. Biochemical and cell biological analyses of a mammalian septin complex, Sept7/9b/11 J. Biol. Chem. 2004, 279 (53) 55895-904 (Pubitemid 40066597)
47. Murakami, M.; Kaul, R.; Kumar, P.; Robertson, E. S. Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus Mol. Cell. Biochem. 2009, 329 (1-2) 131-9
48. Fan, Z.; Beresford, P. J.; Oh, D. Y.; Zhang, D.; Lieberman, J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor Cell 2003, 112 (5) 659-72 (Pubitemid 36331778)
49. Ren, M.; Drivas, G.; D'Eustachio, P.; Rush, M. G. Ran/TC4: a small nuclear GTP-binding protein that regulates DNA synthesis J. Cell Biol. 1993, 120 (2) 313-23 (Pubitemid 23040072)
50. Wamelink, M. M.; Struys, E. A.; Jakobs, C. The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review J. Inherited Metab. Dis. 2008, 31 (6) 703-17
51. Kim, J. W.; Dang, C. V. Multifaceted roles of glycolytic enzymes Trends Biochem. Sci. 2005, 30 (3) 142-50 (Pubitemid 40332530)
52. Toy, G.; Austin, W. R.; Liao, H. I.; Cheng, D.; Singh, A.; Campbell, D. O.; Ishikawa, T. O.; Lehmann, L. W.; Satyamurthy, N.; Phelps, M. E.; Herschman, H. R.; Czernin, J.; Witte, O. N.; Radu, C. G. Requirement for deoxycytidine kinase in T and B lymphocyte development Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (12) 5551-6
53. Burstein, E.; Hoberg, J. E.; Wilkinson, A. S.; Rumble, J. M.; Csomos, R. A.; Komarck, C. M.; Maine, G. N.; Wilkinson, J. C.; Mayo, M. W.; Duckett, C. S. COMMD proteins, a novel family of structural and functional homologs of MURR1 J. Biol. Chem. 2005, 280 (23) 22222-32 (Pubitemid 40827879)
54. Maine, G. N.; Burstein, E. COMMD proteins and the control of the NF kappa B pathway Cell Cycle 2007, 6 (6) 672-6 (Pubitemid 46535678)
55. de Bie, P.; van de Sluis, B.; Burstein, E.; Duran, K. J.; Berger, R.; Duckett, C. S.; Wijmenga, C.; Klomp, L. W. Characterization of COMMD protein-protein interactions in NF-kappaB signalling Biochem. J. 2006, 398 (1) 63-71 (Pubitemid 44231302)
56. Geng, H.; Wittwer, T.; Dittrich-Breiholz, O.; Kracht, M.; Schmitz, M. L. Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination EMBO Rep. 2009, 10 (4) 381-6
57. Maine, G. N.; Mao, X.; Komarck, C. M.; Burstein, E. COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase EMBO J. 2007, 26 (2) 436-47 (Pubitemid 46160944)
58. Mao, X.; Gluck, N.; Li, D.; Maine, G. N.; Li, H.; Zaidi, I. W.; Repaka, A.; Mayo, M. W.; Burstein, E. GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA Genes Dev. 2009, 23 (7) 849-61
59. King, W.; Thomas-Powell, A. L.; Raab-Traub, N.; Hawke, M.; Kieff, E. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line J. Virol. 1980, 36 (2) 506-18 (Pubitemid 10029383)
60. Schlee, M.; Krug, T.; Gires, O.; Zeidler, R.; Hammerschmidt, W.; Mailhammer, R.; Laux, G.; Sauer, G.; Lovric, J.; Bornkamm, G. W. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV J. Virol. 2004, 78 (8) 3941-52 (Pubitemid 38437200)
61. Poirier, F.; Pontet, M.; Labas, V.; le Caer, J. P.; Sghiouar-Imam, N.; Raphael, M.; Caron, M.; Joubert-Caron, R. Two-dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: protein pattern changes following treatment with 5-azycytidine Electrophoresis 2001, 22 (9) 1867-77
62. Klomp, A. E.; van de Sluis, B.; Klomp, L. W.; Wijmenga, C. The ubiquitously expressed MURR1 protein is absent in canine copper toxicosis J. Hepatol. 2003, 39 (5) 703-9 (Pubitemid 37372177)
63. van de Sluis, B.; Mao, X.; Zhai, Y.; Groot, A. J.; Vermeulen, J. F.; van der Wall, E.; van Diest, P. J.; Hofker, M. H.; Wijmenga, C.; Klomp, L. W.; Cho, K. R.; Fearon, E. R.; Vooijs, M.; Burstein, E. COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion J. Clin. Invest. 2010, 120 (6) 2119-30